Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Nostrum Laboratories Inc.
Penalty: $3,825,000
Year: 2023
Date: October 30, 2023
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Violation Description: Nostrum Laboratories Inc. and its founder and CEO agreed to pay a minimum of $3,825,000 and up to $50 million if certain financial contingencies are met to resolve allegations that they violated the False Claims Act by knowingly underpaying Medicaid rebates due for Nostrum's drug Nitrofurantoin Oral Suspension (Nitro OS).
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil
Source of Data: (click here)
Archived Source: (click here)
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.